• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Dapa

Anonymous

Guest
Any word on how we are even comparable to Invokana. How do you respond when the doctor says HOW DO YOU DIFFER FROM INVOKANA. I know start begging and change the subject
 




Any word on how we are even comparable to Invokana. How do you respond when the doctor says HOW DO YOU DIFFER FROM INVOKANA. I know start begging and change the subject

In reading on this drug there appears to be nothing that Invokana cannot offer but bladder cancer and less effectiveness. Bladder cancer will be be the undoing of this drug. Why write it when there is Invokana with no risk. Unbelievable . Come on BJ. LET'S HERE YOUR MOTIVATION